Lv1
100 积分 2024-09-01 加入
Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
The impact of biologics targeting the IL-17 and IL-23 pathways on metabolic indicators in plaque psoriasis
3个月前
已完结
Psoriasis management tree based on comorbidity
4个月前
已完结
皖公网安备34019202002308
